TOP TIERMARKET NEWSWIRE

News & sentiment

JAZZ PHARMACEUTICALS (JAZZ) — News & AI sentiment

JAZZ PHARMACEUTICALS (JAZZ) news roundup. 5 stories in the past week, 31 over 30 days. Average 30-day sentiment is 57.8/100. Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 6 sales totalling $24.4M — net selling of $24.4M. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →

24h stories

0

7d stories

5

avg sentiment 60.8/100

30d stories

31

avg sentiment 57.8/100

Insider net (90d)

$24.4M

0 buys · 6 sells

Congress (90d)

0

0 buys · 0 sells

JAZZ news in the last 24 hours, 7 days, 30 days and 90 days

How much JAZZ coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time window	JAZZ stories	Avg AI sentiment	Read
Last 24 hours	0	—	no coverage
Last 7 days	5	60.8/100	JAZZ headlines →
Last 30 days	31	57.8/100	JAZZ headlines →
Last 90 days	73	59/100	JAZZ headlines →

Latest stories on JAZZ

UBS raises Jazz Pharmaceuticals stock price target on Ziihera approval

Investing.com Analyst Ratings71 · bullishanalyst

2d ago

Jazz Pharmaceuticals price target raised to $337 from $315 at UBS

The Fly61 · neutralanalyst

2d ago

Jazz Pharmaceuticals plc (JAZZ) Presents at Citigroup's Biopharma Back to School Summit 2026 Transcript

Seeking Alpha56 · neutralgeneral

3d ago

Jazz Pharmaceuticals price target raised to $271 from $270 at Barclays

The Fly61 · neutralanalyst

3d ago

Jazz Pharmaceuticals plc (JAZZ) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript

Seeking Alpha55 · neutralgeneral

4d ago

Jazz Pharmaceuticals to Participate in Upcoming Investor Conferences

PR Newswire56 · neutralgeneral

Sep 2

Canaccord reiterates Jazz Pharmaceuticals stock rating on trial data

Investing.com Analyst Ratings56 · neutralanalyst

Sep 1

Jazz Pharmaceuticals plc (JAZZ) files 8-K

SEC 8-K50 · neutralgeneral

Aug 31

Jazz reports second interim overall survival results for HERIZON-GEA-01 trial

The Fly59 · neutralproduct/pr

Aug 31

Jazz Pharmaceuticals price target raised to $299 from $277 at RBC Capital

The Fly61 · neutralanalyst

Aug 28

Jazz Pharmaceuticals prices upsized $1.1B offering of exchangeable senior notes

The Fly28 · bearishgeneral

Aug 27

Jazz Pharmaceuticals prices upsized $1.1B private debt offering

Seeking Alpha28 · bearishgeneral

Aug 27

Jazz Pharmaceuticals Announces Pricing of Upsized Private Offering of $1.1 Billion of 1.875% Exchangeable Senior Notes due 2032 and Concurrent Ordinary Share Repurchases

PR Newswire28 · bearishgeneral

Aug 27

Truist raises Jazz Pharmaceuticals stock price target on drug approval

Investing.com Analyst Ratings63 · neutralanalyst

Aug 26

RBC Capital raises Jazz Pharmaceuticals stock price target on label

Investing.com Analyst Ratings61 · neutralanalyst

Aug 26

Jazz Pharmaceuticals price target raised to $281 from $264 at Truist

The Fly61 · neutralanalyst

Aug 26

Jazz Pharmaceuticals price target raised to $322 from $283 at Morgan Stanley

The Fly67 · bullishanalyst

Aug 26

Needham raises Jazz Pharmaceuticals stock price target on Ziihera

Investing.com Analyst Ratings61 · neutralanalyst

Aug 26

Jazz Pharmaceuticals announces private offering of $1B of exchangeable senior notes due 2032 and concurrent share repurchases

Seeking Alpha53 · neutralgeneral

Aug 26

Jazz Pharmaceuticals price target raised to $310 from $292 at Needham

The Fly61 · neutralanalyst

Aug 26

Jazz Pharmaceuticals Announces Private Offering of $1.0 Billion of Exchangeable Senior Notes due 2032 and Concurrent Ordinary Share Repurchases

PR Newswire45 · neutralgeneral

Aug 26

Jazz Pharmaceuticals price target raised to $300 from $287 at Deutsche Bank

The Fly61 · neutralanalyst

Aug 26

Deutsche Bank raises Jazz Pharmaceuticals stock price target on FDA approval

Investing.com Analyst Ratings67 · bullishanalyst

Aug 26

Jazz Pharmaceuticals plc (JAZZ) Discusses FDA Approval and Commercial Launch of ZIIHERA for First-Line HER2-Positive GEA Transcript

Seeking Alpha73 · bullishproduct/pr

Aug 26

Jazz wins FDA nod for Ziihera gastric cancer use

TipRanks73 · bullishproduct/pr

Aug 25

Open JAZZ in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →